Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD3 epsilon antibody

The Mouse Monoclonal anti-CD3 epsilon antibody has been validated for ELISA, Func, Neut and IGA. It is suitable to detect CD3 epsilon in samples from Human.
Catalog No. ABIN7795311

Quick Overview for Recombinant CD3 epsilon antibody (ABIN7795311)

Target

See all CD3 epsilon (CD3E) Antibodies
CD3 epsilon (CD3E)

Antibody Type

Recombinant Antibody

Reactivity

  • 350
  • 189
  • 51
  • 43
  • 21
  • 19
  • 8
  • 8
  • 8
  • 7
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
Human

Host

  • 207
  • 175
  • 35
  • 35
  • 23
  • 10
  • 7
  • 2
  • 2
  • 1
  • 1
Mouse

Clonality

  • 375
  • 115
  • 7
Monoclonal

Conjugate

  • 175
  • 37
  • 34
  • 23
  • 22
  • 12
  • 11
  • 11
  • 11
  • 11
  • 11
  • 11
  • 8
  • 8
  • 7
  • 7
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD3 epsilon antibody is un-conjugated

Application

  • 352
  • 213
  • 180
  • 127
  • 115
  • 87
  • 47
  • 32
  • 32
  • 27
  • 23
  • 22
  • 21
  • 14
  • 13
  • 8
  • 6
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Functional Studies (Func), Neutralization (Neut), Immunogenicity Assay (IGA)

Grade

In vivo Grade

Clone

OKT3
  • Expression System

    Mammalian cells

    Purpose

    In vivo Grade Recombinant Anti-human CD3e Monoclonal Antibody, Mouse IgG2a Kappa (Clone: OKT3)

    Characteristics

    The OKT3 antibody binds to CD3 epsilon of the T cell receptor-CD3 complex found only on mature T cells and medullary thymocytes. An interaction between T cells, OKT3, and monocytes causes T-cell activation (mitogenesis) in vitro. On the other hand, the OKT3 antibody blocks the unique association between the antigen receptor and CD3, and both the generation and function of cytotoxic T cells. After an initial dose of the OKT3 antibody, T cells disappear from the circulation within minutes to hours. During treatment with the OKT3 antibody, T cells bearing the usual array of surface molecules (CD2, CD4, and CD8) reappear in the peripheral blood circulation but these cells are devoid of CD3. After another 48 hours without the OKT3 antibody, the normal array of surface molecules including CD3 appear again on all T cells. The selective removal of CD3 by internalization is thought to be the key mechanism of action of the OKT3 antibody. Comodulation of the antigen receptor with CD3 explains the immunoblocking action of the OKT3 antibody in vivo. The OKT3 antibody is ineffective clinically if the CD3 target molecule is not modulated. The OKT3 antibody is effective for induction of immunosuppression and for treating initial and steroid-resistant rejections.

    Purification

    Protein A or G affinity column

    Purity

    >95 % by reducing SDS-PAGE

    Endotoxin Level

    < 1 EU per 1 mg of the protein by the LAL method

    Isotype

    IgG2a
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    > 3 mg/mL

    Storage

    4 °C,-20 °C

    Storage Comment

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • Target

    CD3 epsilon (CD3E)

    Alternative Name

    CD3e

    Pathways

    TCR Signaling, CXCR4-mediated Signaling Events, Ubiquitin Proteasome Pathway
You are here:
Chat with us!